Stay updated on Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.

Latest updates to the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedThe page versioning shows a new revision, v3.5.0, added and the previous revision, v3.4.3, removed.SummaryDifference0.1%

- Check31 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 from the page.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.2 is now shown and the prior notice about government funding (v3.4.1) has been removed; these are administrative updates that do not alter the study details or user interactions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check66 days agoChange DetectedAdded a site-wide notice about government funding and operating status and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check74 days agoChange DetectedGlossary toggle added; the QC status label now reads 'Last Update Submitted that Met QC Criteria' and the footer includes 'No FEAR Act Data' with revision updated to v3.4.0, replacing the previous 'Last Update Submitted that met QC Criteria' and revision v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check81 days agoChange DetectedKey documents including the Statistical Analysis Plan and Study Protocol were removed from the Study Documents section, along with related items such as IPD plans.SummaryDifference17%

Stay in the know with updates to Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emapalumab in Adult HLH: Efficacy & Safety Clinical Trial page.